The high case-fatality rate of confirmed MERS-CoV infections underlines the urgent need for
an effective treatment to reduce the disease severity and mortality. REGN3051 and …

Highlights•MERS-CoV vaccines for dromedary camels and their human contacts can
potentially stop virus transmission in the community.•Both neutralizing antibody and T-cell …

Middle East respiratory syndrome coronavirus (MERS-CoV) emerged into the human
population in 2012 and has caused substantial morbidity and mortality. Potently neutralizing …

MERS-CoV seronegative and seropositive camels received a single intramuscular dose of
ChAdOx1 MERS, a replication-deficient adenoviral vectored vaccine expressing MERS-CoV …

Human coronaviruses cause both upper and lower respiratory tract infections in humans. In
2012, a sixth human coronavirus (hCoV) was isolated from a patient presenting with severe …

Background The recent emergence of a novel coronavirus in the Middle East (designated
MERS-CoV) is a reminder of the zoonotic and pathogenic potential of emerging …

Middle East respiratory syndrome coronavirus (MERS-CoV) has recently emerged as a
causative agent of severe respiratory disease in humans. Here, we constructed recombinant …

Since 2012, MERS-CoV has caused up to 2220 cases and 790 deaths in 27 countries with
Saudi Arabia being the most affected country with~ 83.1% of the cases and~ 38.8% local …

Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory
disease in humans. We tested a recombinant modified vaccinia virus Ankara (MVA) vaccine …

Middle East respiratory syndrome (MERS), an emerging infectious disease caused by
MERS coronavirus (MERS-CoV), has garnered worldwide attention as a consequence of its …